CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
Subscribe To Our Newsletter & Stay Updated